{"title":"Coenzyme Q0, a quinone derivative from Antrodia camphorata, triggered ROS-mediated cytoprotective autophagy in human promyelocytic leukemia cells","authors":"Hsin-Ling Yang , Pei-Yuan Chiu , Hui-Jye Chen , Sudhir Pandey , Yue-Tong Chen , Siang-Jyun Chen , Yu-Lyu Yeh , Hsueh-Wei Chang , Jhih-Hsuan Hseu , You-Cheng Hseu","doi":"10.1016/j.jff.2025.106939","DOIUrl":null,"url":null,"abstract":"<div><div>Our previous investigation revealed that Coenzyme Q<sub>0</sub> (CoQ<sub>0</sub>), a quinone derivative from <em>Antrodia camphorata</em>, triggered ROS-dependent voltage-dependent anion channel 1 (VDAC-1)-mediated apoptosis in human promyelocytic leukemia (HL-60) cells. This research examined the efficacies of CoQ<sub>0</sub> (0–7 μM) on autophagy induction and the interaction between apoptosis and autophagy in HL-60 cells. CoQ<sub>0</sub>-triggered autophagy was associated with LC3-I/II accumulation, p62/SQSTM1 activation, autolysosome AVOs formation, ATG4B inhibition, ATG5/ATG7 expression, and Beclin-1/Bcl-2 dysregulation in HL-60 cells. Additionally, antioxidant <em>N</em>-acetylcysteine (NAC) prevented CoQ<sub>0</sub>-induced autophagy in HL-60 cells. Surprisingly, CoQ<sub>0</sub>-triggered cell death was enhanced by autophagy inhibitor 3-MA or CQ, indicating that autophagy acts as a survival mechanism. Additionally, autophagy suppression <em>via</em> 3-MA and/or CQ inhibitors strengthened the CoQ<sub>0</sub>-induced ROS generation and apoptosis (caspase-3 activation). Apoptosis suppression by caspase inhibitor <em>Z</em>-VAD-FMK or VDAC-1 silencing prevented the CoQ<sub>0</sub>-enhanced autophagy in HL-60 cells. Therefore, CoQ<sub>0</sub> together with autophagy inhibitors could be a potential therapy for human promyelocytic leukemia.</div></div>","PeriodicalId":360,"journal":{"name":"Journal of Functional Foods","volume":"131 ","pages":"Article 106939"},"PeriodicalIF":4.0000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Functional Foods","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756464625002816","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Our previous investigation revealed that Coenzyme Q0 (CoQ0), a quinone derivative from Antrodia camphorata, triggered ROS-dependent voltage-dependent anion channel 1 (VDAC-1)-mediated apoptosis in human promyelocytic leukemia (HL-60) cells. This research examined the efficacies of CoQ0 (0–7 μM) on autophagy induction and the interaction between apoptosis and autophagy in HL-60 cells. CoQ0-triggered autophagy was associated with LC3-I/II accumulation, p62/SQSTM1 activation, autolysosome AVOs formation, ATG4B inhibition, ATG5/ATG7 expression, and Beclin-1/Bcl-2 dysregulation in HL-60 cells. Additionally, antioxidant N-acetylcysteine (NAC) prevented CoQ0-induced autophagy in HL-60 cells. Surprisingly, CoQ0-triggered cell death was enhanced by autophagy inhibitor 3-MA or CQ, indicating that autophagy acts as a survival mechanism. Additionally, autophagy suppression via 3-MA and/or CQ inhibitors strengthened the CoQ0-induced ROS generation and apoptosis (caspase-3 activation). Apoptosis suppression by caspase inhibitor Z-VAD-FMK or VDAC-1 silencing prevented the CoQ0-enhanced autophagy in HL-60 cells. Therefore, CoQ0 together with autophagy inhibitors could be a potential therapy for human promyelocytic leukemia.
期刊介绍:
Journal of Functional Foods continues with the same aims and scope, editorial team, submission system and rigorous peer review. We give authors the possibility to publish their top-quality papers in a well-established leading journal in the food and nutrition fields. The Journal will keep its rigorous criteria to screen high impact research addressing relevant scientific topics and performed by sound methodologies.
The Journal of Functional Foods aims to bring together the results of fundamental and applied research into healthy foods and biologically active food ingredients.
The Journal is centered in the specific area at the boundaries among food technology, nutrition and health welcoming papers having a good interdisciplinary approach. The Journal will cover the fields of plant bioactives; dietary fibre, probiotics; functional lipids; bioactive peptides; vitamins, minerals and botanicals and other dietary supplements. Nutritional and technological aspects related to the development of functional foods and beverages are of core interest to the journal. Experimental works dealing with food digestion, bioavailability of food bioactives and on the mechanisms by which foods and their components are able to modulate physiological parameters connected with disease prevention are of particular interest as well as those dealing with personalized nutrition and nutritional needs in pathological subjects.